lanadelumab

Italy

Drugs containing this active substance

  • TAKHZYRO

    TAKHZYRO is used to prevent angioedema attacks (HAE) in patients aged 2 years and older.

    Form: solution for injection

    Active substance Dosage
    lanadelumab -

    ATC: B06AC05

    Manufacturer: TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH